163 related articles for article (PubMed ID: 38052820)
21. Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion.
Roversi FM; Cury NM; Lopes MR; Ferro KP; Machado-Neto JA; Alvarez MC; Dos Santos GP; Giardini Rosa R; Longhini AL; Duarte ADSS; Pericole FV; Favaro P; Yunes JA; Saad STO
J Cell Mol Med; 2019 Feb; 23(2):1562-1571. PubMed ID: 30484958
[TBL] [Abstract][Full Text] [Related]
22. Skin mesenchymal niches maintain and protect AML-initiating stem cells.
Sandhow L; Cai H; Leonard E; Xiao P; Tomaipitinca L; Månsson A; Kondo M; Sun X; Johansson AS; Tryggvason K; Kasper M; Järås M; Qian H
J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37516911
[TBL] [Abstract][Full Text] [Related]
23. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
Wu J; Zhang Y; Li X; Ren J; Chen L; Chen J; Cao Y
Biochem Biophys Res Commun; 2022 Sep; 622():149-156. PubMed ID: 35863089
[TBL] [Abstract][Full Text] [Related]
24. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
Mei S; Zhang Y; Yu L; Chen G; Zi F
Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
26. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
[TBL] [Abstract][Full Text] [Related]
27. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
28. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
29. The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells.
Viñado AC; Calvo IA; Cenzano I; Olaverri D; Cocera M; San Martin-Uriz P; Romero JP; Vilas-Zornoza A; Vera L; Gomez-Cebrian N; Puchades-Carrasco L; Lisi-Vega LE; Apaolaza I; Valera P; Guruceaga E; Granero-Molto F; Ripalda-Cemborain P; Luck TJ; Bullinger L; Planes FJ; Rifon JJ; Méndez-Ferrer S; Yusuf RZ; Pardo-Saganta A; Prosper F; Saez B
Leukemia; 2022 Aug; 36(8):1969-1979. PubMed ID: 35618797
[TBL] [Abstract][Full Text] [Related]
30. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
Yankova E; Blackaby W; Albertella M; Rak J; De Braekeleer E; Tsagkogeorga G; Pilka ES; Aspris D; Leggate D; Hendrick AG; Webster NA; Andrews B; Fosbeary R; Guest P; Irigoyen N; Eleftheriou M; Gozdecka M; Dias JML; Bannister AJ; Vick B; Jeremias I; Vassiliou GS; Rausch O; Tzelepis K; Kouzarides T
Nature; 2021 May; 593(7860):597-601. PubMed ID: 33902106
[TBL] [Abstract][Full Text] [Related]
31. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.
Azadniv M; Myers JR; McMurray HR; Guo N; Rock P; Coppage ML; Ashton J; Becker MW; Calvi LM; Liesveld JL
Leukemia; 2020 Feb; 34(2):391-403. PubMed ID: 31492897
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of AML Mouse Model by Transplantation of Hematopoietic Cells from MLL-AF9 Transgenic Mice].
Long WY; Shen X; Xing S; Xiong GL; Wang HG; Yu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1369-1374. PubMed ID: 34627412
[TBL] [Abstract][Full Text] [Related]
34. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
Tamura M; Yonezawa T; Liu X; Asada S; Hayashi Y; Fukuyama T; Tanaka Y; Kitamura T; Goyama S
Sci Rep; 2019 Jun; 9(1):8171. PubMed ID: 31160638
[TBL] [Abstract][Full Text] [Related]
35. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
[TBL] [Abstract][Full Text] [Related]
36. miR‑30a‑5p induces the adipogenic differentiation of bone marrow mesenchymal stem cells by targeting FAM13A/Wnt/β‑catenin signaling in aplastic anemia.
Wang E; Zhang Y; Ding R; Wang X; Zhang S; Li X
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34821370
[TBL] [Abstract][Full Text] [Related]
37. [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
Wang XS; He JR; Yu S; Yu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Jun; 40(3):308-314. PubMed ID: 29978784
[TBL] [Abstract][Full Text] [Related]
38. IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
Zhang Y; Guo H; Zhang Z; Lu W; Zhu J; Shi J
Exp Cell Res; 2022 Jun; 415(1):113112. PubMed ID: 35346671
[TBL] [Abstract][Full Text] [Related]
39. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
40. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
